AC Immune SA (ACIU)
3.285
+0.04
(+1.39%)
USD |
NASDAQ |
Nov 21, 16:00
3.285
0.00 (0.00%)
After-Hours: 19:48
AC Immune Price to Book Value: 2.101 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 20, 2024 | 2.072 |
November 19, 2024 | 2.091 |
November 18, 2024 | 2.005 |
November 15, 2024 | 2.04 |
November 14, 2024 | 2.270 |
November 13, 2024 | 2.002 |
November 12, 2024 | 1.957 |
November 11, 2024 | 2.027 |
November 08, 2024 | 2.046 |
November 07, 2024 | 2.091 |
November 06, 2024 | 1.976 |
November 05, 2024 | 2.072 |
November 04, 2024 | 1.880 |
November 01, 2024 | 1.918 |
October 31, 2024 | 1.816 |
October 30, 2024 | 1.899 |
October 29, 2024 | 1.925 |
October 28, 2024 | 1.918 |
October 25, 2024 | 1.950 |
October 24, 2024 | 1.918 |
October 23, 2024 | 1.944 |
October 22, 2024 | 1.989 |
October 21, 2024 | 1.963 |
October 18, 2024 | 2.002 |
October 17, 2024 | 2.053 |
Date | Value |
---|---|
October 16, 2024 | 2.04 |
October 15, 2024 | 2.046 |
October 14, 2024 | 2.04 |
October 11, 2024 | 2.123 |
October 10, 2024 | 2.136 |
October 09, 2024 | 2.168 |
October 08, 2024 | 2.117 |
October 07, 2024 | 2.174 |
October 04, 2024 | 2.162 |
October 03, 2024 | 2.168 |
October 02, 2024 | 2.225 |
October 01, 2024 | 2.398 |
September 30, 2024 | 2.417 |
September 27, 2024 | 2.702 |
September 26, 2024 | 2.666 |
September 25, 2024 | 2.659 |
September 24, 2024 | 2.681 |
September 23, 2024 | 2.637 |
September 20, 2024 | 2.659 |
September 19, 2024 | 2.659 |
September 18, 2024 | 2.616 |
September 17, 2024 | 2.493 |
September 16, 2024 | 2.356 |
September 13, 2024 | 2.292 |
September 12, 2024 | 2.198 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7361
Minimum
Dec 22 2022
3.597
Maximum
Dec 29 2023
1.786
Average
1.777
Median
Jun 10 2020
Price to Book Value Benchmarks
CRISPR Therapeutics AG | 2.037 |
Addex Therapeutics Ltd | 0.6249 |
NLS Pharmaceutics Ltd | -- |
Molecular Partners AG | 1.192 |
MoonLake Immunotherapeutics | 6.719 |
Price to Book Value Related Metrics
Price to Free Cash Flow | 6.184 |
Price | 3.285 |
Earnings Yield | -13.97% |
Market Cap | 325.03M |